Insurers say advances in medical care are prompting them to review more cases before deciding on coverage. They say the checks are not meant to delay or stifle care, but doctors say they worry about the growing influence insurers have over patient treatment.
The company, eHealth Inc., is led by Scott Flanders, an Indianapolis native and former CEO of Macmillan Publishing in Carmel and Playboy Enterprises in Chicago.
The new publicly traded company will have sales of about $19 billion to $20 billion in 2020, the drugmakers said in a statement.
Many of the providers are not traditional health systems, but rather small, for-profit startups attracted by a soaring demand for recovery services.
A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday.
Young is out front nationally on a key anti-smoking platform: Raising the minimum age for buying tobacco to 21.
Indianapolis-based Anthem Inc. topped second quarter expectations and raised its 2019 forecast again. The health insurer also said Wednesday that the start of its new pharmacy benefit manager is going better than expected.
Iowa Republican Charles Grassley and Oregon Democrat Ron Wyden said the bill would for the first time limit drug copays for people with Medicare’s “Part D” prescription plan, by capping patients’ out-of-pocket costs.
U.S. overdose deaths last year likely fell for the first time in nearly three decades, preliminary statistics suggest.
Doctors fighting a reimbursement battle with one of the biggest U.S. health insurers want to make sure that ending surprise medical bills doesn’t come at the expense of their pay.
Violators could be charged up to $50 for their first violation and up to $500 for more violations in the same year.
The drug rebate rule would have ended a widespread practice in which drugmakers give rebates to insurance middlemen in government programs such as Medicare. The idea was to channel that money to consumers instead.
The nonpartisan Congressional Budget Office estimated the plan would have little impact on manufacturer prices and cost Medicare $177 billion over 10 years by leading to higher premiums subsidized by taxpayers.
Lilly shares dropped 4.6 percent in early trading after the company said Christi Shaw was leaving and Mike Harrington planned to retire.
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
A federal appeals court seemed inclined Tuesday to rule that the core provision of President Barack Obama’s signature health care law is unconstitutional.
The multibillion-dollar merger would combine Elanco, the fourth-largest global player in animal health, with Bayer’s pet-health division, which ranks fifth in veterinary medicine, Reuters reported. The combination would create a dominant force in the industry.
The fate of former President Barack Obama's signature health care law, and its coverage and insurance protections for millions of Americans, is again being argued in a case that appears destined for the Supreme Court.
Responding to a lawsuit by Eli Lilly and two other companies, a federal judge Monday blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads.
The owner of Pendleton-based Steele Financial Inc., who is already in hot water with the Financial Industry Regulatory Authority and the SEC, has been stripped of her license by the Indiana Department of Insurance.
